Top Cheapest Companies To Watch For 2014

In the following video, Fool contributor Matt Thalman discusses one reason all investors should take a closer look at Amazon.com.

Matt thinks the company’s ecosystem has been built to last and will allow Amazon to dominate the retail space in the coming years. Amazon’s business model is very similar to the razor-and-blade concept investors are familiar with, with the main difference being that once Amazon sells you the razor, it can sell more than just the blades to go along with it. That’s something that many of the other dominant players in the technology world can’t do.

Check out the video for more details

The best investing approach is to choose great companies and stick with them for the long term. The Motley Fool’s free report “3 Stocks That Will Help You Retire Rich” names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.

Top Cheapest Companies To Watch For 2014: Koninklijke Philips Electronics N.V.(PHG)

Koninklijke Philips Electronics N.V. engages in the healthcare, consumer lifestyle, and lighting product businesses worldwide. The company offers screening, diagnosis, treatment, monitoring, and health management services in cardio-pulmonary, oncology, and women?s health areas. Its healthcare products and solutions include X-rays, computed tomography, magnetic resonance, nuclear medicine, and ultrasound imaging equipment; and cardiology informatics and diagnostic electrocardiography, radiology information systems, picture archiving and communication systems, patient monitoring and clinical informatics, perinatal care, and therapeutic care systems. The company?s healthcare products and solutions also consist of sleep management and respiratory care, medical alert, remote cardiac, and remote patient management services. In addition, it offers consultancy, site planning and project management, clinical, education, equipment financing, asset management, and equipment mainten a nce and repair services. The company?s consumer lifestyle products and solutions comprise mother and childcare, oral healthcare, male grooming, skincare, and beauty products; coffee, floor and garment care, kitchen, water and air, and beverage appliances; and communication and control, audio and multimedia, speech processing, headphones and accessories, and home cinema and video products. Its lighting solutions include lamps, including incandescent, halogens, fluorescent, high-intensity discharge, and LED lamps; consumer luminaires for functional, decorative, lifestyle, and scene-setting applications; professional luminaires for city beautification, and road, sports, shop/hospitality, and industry lighting applications; systems and controls, that include electronic and electromagnetic gears, controls, modules, and drivers; automotive lighting, such as car headlights, car signaling, and interior; and packaged LEDs. The company was founded in 1891 and is headquartered in Ams t erdam, the Netherlands.

Advisors’ Opinion:

  • [By MONEYMORNING]

    In other words, Allegion’s offerings range from low-tech – steel doors and conventional locks – to high tech: automated-access and security systems, video monitoring, and systems integration. Its 23 business brands include:

    Interflex Datensysteme GmbH & Co. KG, which offers such workforce-management systems as time accounting and automated scheduling, as well as security systems that include ID and access-card production, closed-circuit (CCTV) video surveillance, and biometrics. CISA, a security pioneer that patented the first electrically controlled lock – back in 1926. It is also the first brand in the world to develop smart-card locks, which are used as electronic keys to safely and efficiently manage gates and entrances. CISA today develops and markets cylinders and locks for any kind of door, including electronic locks, panic bars, door closers, safes, and padlocks. aptiQ Smart Technology, which uses an “open-architecture” to design readers, credentials, and smartphone-based security applications. The aptiQ portfolio includes easy-to-use readers that can accommodate most magnetic-stripe cards. This product line also allows for the creation and use of proximity cards, aptiQ “smartcards,” and the latest in so-called “near-field communications” (NFC) technology – the know-how behind our May 2012 recommendation of NXP Semiconductors NV (Nasdaq: NXPI), a stock that has more than doubled. (Coincidentally, NXP is a 2006 spinoff from Koninklijke Philips Electronics NV (NYSE ADR: PHG) – which underscores, again, the profit potential of “spin-off investing.”) Bocom Systems, which specializes in video monitoring solutions for city and highway traffic, as well as for airports, government buildings, and general surveillance. That business unit designs, engineers, and installs both security alarm systems and more-complex closed-circuit-based security networks. And Schlage, a 90-year-old company that’s one of the top nam

  • [By Ben Levisohn]

    Shares of GE have gained 3.5% to $24.54 at 1:08 p.m. today. United Technologies (UTX) has dropped 0.6% to $107.37, Koninklijke Philips (PHG) has gained 0.8% to $33.40, Siemens (SI) has risen 1.5% to $124.40 and 3M (MMM) has ticked up 0.1% to $122.75.

  • [By Steve Symington]

    Enter Dolby 3D
    That’s why I’m so intrigued by Monday’s news that Dolby (NYSE: DLB  ) and Philips (NYSE: PHG  ) have collaborated in a joint project to create a new content delivery specification for the Dolby 3D format, which will be part of a “suite of technologies” to more easily allow content creators the ability to make, deliver, and play back glasses-free 3-D content.

  • [By Rich Duprey]

    But last year’s L prize winner, Koninklijke Philips Electronics (NYSE: PHG  ) , says it also has the next advance in LED lighting that will be more efficient and slightly more affordable than its oft-ridiculed predecessor. The lighting specialist says it has developed an LED bulb that can produce 200 lumens of light per watt, a threshold that puts it at about double what a typical fluorescent bulb generates. While it will cost slightly more than its fluorescent rival, the total cost of ownership of the bulb will be much less.

Top Cheapest Companies To Watch For 2014: Artek Exploration Ltd (ARKXF.PK)

Artek Exploration Ltd. (Artek) is a junior oil and gas company engaged in the exploration for, and the acquisition, development and production of, oil and natural gas reserves in western Canada. Artek’s principal properties include Peace River Arch, Alberta; Deep Basin, Alberta and British Columbia; Inga/Fireweed, British Columbia, and Central Alberta. During the year ended December 31, 2011, the Company drilled six gross (3.7 net) wells, including two gross (1.6 net) oil wells and four gross (2.1 net) natural gas wells. On June 20, 2012, it had drilled and completed its second of a seven horizontal well program (60% working interest) at its Doig natural gas and condensate pool in the Inga area of British Columbia. On January 1, 2012, the Company divested 33% of its non-operated oil and gas assets in the Leduc Woodbend area. In August 2013, the Company announced that it has completed the acquisition of Fireweed asset. Advisors’ Opinion:

  • [By Value Digger]

    As peers, I selected Artek Exploration (ARKXF.PK), RMP Energy (OEXFF.PK), Synergy Resources (SYRG) and Magnum Hunter Resources (MHR). The first two firms trade also on the main Toronto board under the tickers RTK.TO and RMP.TO respectively. These peers comply with the following criteria:

Top Cheapest Companies To Watch For 2014: Cell Therapeutics Inc (CTIC)

Cell Therapeutics, Inc. (CTI), incorporated in 1991, develops, acquires and commercializes treatments for cancer. The Company’s research, development, acquisition and in-licensing activities concentrate on identifying and developing new ways to treat cancer. As of December 31, 2011, CTI focused its efforts on Pixuvri (pixantrone dimaleate) (Pixuvri), OPAXIO (paclitaxel poliglumex) (OPAXIO), tosedostat, brostallicin and bisplatinates. As of December 31, 2011, it developed Pixuvri, an anthracycline derivative for the treatment of hematologic malignancies and solid tumors. Another late-stage drug candidate of the Company, OPAXIO, is being studied as a potential maintenance therapy for women with advanced stage ovarian cancer, who achieve a complete remission following first-line therapy with paclitaxel and carboplatin. As of December 31, 2011, it also developed tosedostat in collaboration with Chroma Therapeutics, Ltd. (Chroma). On May 31, 2012, CTI completed its acquisitio n gaining worldwide rights to S*BIO Pte Ltd.’s (S*BIO) pacritinib.

Pixuvri

As of December 31, 2011, the Company developed Pixuvri, an aza-anthracenedione derivative, for the treatment of non-Hodgkin’s lymphoma (NHL), and various other hematologic malignancies, and solid tumors. Pixuvri was studied in the Company’s EXTEND, or PIX301, clinical trial, which was a phase III single-agent trial of Pixuvri for patients with relapsed, refractory aggressive NHL who received two or more prior therapies and who were sensitive to treatment with anthracyclines. On September 28, 2011, CTI announced that a second independent radiology assessment of response and progression endpoint data from its PIX301 clinical trial of Pixuvri was achieved with statistical significance. The results of the EXTEND trial met its primary endpoint and showed that patients randomized to treatment with Pixuvri achieved a significantly higher rate of confirmed and unconfirmed compl ete response compared to patients treated with standard chem! otherapy had a significantly increased overall response rate and experienced a statistically significant improvement in median progression free survival. Pixuvri had predictable and manageable toxicities when administered at the proposed dose and schedule in the EXTEND clinical trial in heavily pre-treated patients. In March 2011, the Company initiated the PIX-R trial to study Pixuvri in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). Pixuvri has also been studied in patients with HER2-negative metastatic breast cancer who have tumor progression after at least two, but not more than three, prior chemotherapy regimens. In the second quarter of 2010, the NCCTG opened this phase II study for enrollment. The study is closed to accrual and results are expected to be reported by the NCCTG later in 2012.

OPAXIO

OPAXIO is the Company’s biologically-enhanced chemotherapeutic agent that links paclitax el to a biodegradable polyglutamate polymer, resulting in a new chemical entity. As of December 31, 2011, the Company focused its development of OPAXIO on ovarian, brain, esophageal, head and neck cancer. OPAXIO was designed to improve the delivery of paclitaxel to tumor tissue while protecting normal tissue from toxic side effects. In November 2010, results were presented by the Brown University Oncology Group from a phase II trial of OPAXIO combined with temozolomide (TMZ), and radiotherapy in patients with newly-diagnosed, high-grade gliomas, a type of brain cancer. The trial demonstrated a high rate of complete and partial responses and a high rate of six month progression free survival (PFS). Based on these results, the Brown University Oncology Group has initiated a randomized, multicenter, phase II study of OPAXIO and standard radiotherapy versus TMZ and radiotherapy for newly diagnosed patients with glioblastoma with an active gene termed MGMT that reduces responsive ness to TMZ. A phase I/II study of OPAXIO combined with radi! otherapy ! and cisplatin was initiated by SUNY Upstate Medical University, in patients with locally advanced head and neck cancer.

Tosedostat

In March 2011, the Company entered into a co-development and license agreement with Chroma Therapeutics, Ltd. (Chroma), providing the Company with marketing and co-development rights to Chroma’s drug candidate, tosedostat, in North, Central and South America. Tosedostat is an oral, aminopeptidase inhibitor that has demonstrated anti-tumor responses in blood related cancers and solid tumors in phase I-II clinical trials. Interim results from the phase II OPAL study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia (AML) showed that once-daily, oral doses of tosedostat had predictable and manageable toxicities and results demonstrated response rates, including a high-response rate among patients who received prior hypomethylating agents, which are used to treat myelodysplastic syndrom e (MDS), a precursor of AML.

Brostallicin

As of December 31, 2011, the Company developed brostallicin through its wholly owned subsidiary, Systems Medicine LLC, which holds rights to use, develop, import and export brostallicin. Brostallicin is a synthetic deoxyribonucleic acid (DNA) minor groove binding agent that has demonstrated anti-tumor activity and a favorable safety profile in clinical trials, in which more than 230 patients have been treated as of December 31, 2011. The Company uses a genomic-based platform to guide the development of brostallicin. A phase II study of brostallicin in relapsed, refractory soft tissue sarcoma met its predefined activity and safety hurdles and resulted in a first-line phase II clinical trial study that was conducted by the European Organization for Research and Treatment of Cancer (EORTC).

The Company competes with Bristol-Myers Squibb Company, Sanofi-Aventis, Pfizer, Roche Group, Genentech, Inc ., Astellas Pharma, Eli Lilly and Company, Celgene, Telik, I! nc., TEVA! Pharmaceuticals Industries Ltd. and PharmaMar.

Advisors’ Opinion:

  • [By MONEYMORNING]

    Cell Therapeutics Inc. (Nasdaq: CTIC), based in Seattle, Wash., acquires, develops, and commercializes treatments for cancers, including non-Hodgkin’s leukemia and ovarian, neck, and brain cancers. The company just announced it has completed patient enrollment in clinical trials for an investigational agent to be used as a maintenance therapy in ovarian cancer patients. The trial is being conducted by the Gynecologic Oncology Group, one of the National Cancer Institute’s funded research groups. Roth Capital recently reiterated a “Buy” rating on the stock and raised its price target from $6 to $7. Roth believes the company’s treatment for leukemia, Pacritinib, is effectively evolving. Additionally, the investment firm sees potential in CTIC’s Tosedostat, which deprives tumor cells of the amino acid building blocks needed to make proteins necessary for tumor cell survival. Shares rose 2% Tuesday to $3.52 on volume of 6 million shares.

  • [By John Udovich]

    The start of 2014 shows that biotech is still a hot area with the sector along with small cap biotech stocks like AMAG Pharmaceuticals, Inc (NASDAQ: AMAG), Mast Therapeutics Inc (NYSEMKT: MSTX), Cell Therapeutics Inc (NASDAQ: CTIC), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and TNI BioTech (OTCMKTS: TNIB) producing news or returns plus Auspex Pharmaceuticals (NASDAQ: ASPX), Cara Therapeutics (NASDAQ: CARA), Egalet (NASDAQ: EGLT), Flexion Therapeutics (NASDAQ: FLXN) and Ultragenyx Pharmaceutical (NASDAQ: RARE) are among the (many…) planned biotech IPOs that have recently been announced publicly:

  • [By Bryan Murphy]

    Like it or not, all good things must come to an end…. even for a red hot stock like Cell Therapeutics Inc. (NASDAQ:CTIC). Yes, CTIC is up 111% since the end of 2013, up 14% today alone, and it doesn’t look like the bulls have any reason to slow down now. That’s exactly why now’s the time for current shareholders to be afraid, however – expect it when you least expect it.

Top Cheapest Companies To Watch For 2014: ATP Oil And Gas Corp (AOB)

ATP Oil & Gas Corporation, incorporated in 1991, is engaged in the acquisition, development and production of oil and natural gas properties. As of December 31, 2011, the Company had estimated net proved reserves of 118.9 Million barrels of crude oil equivalent (MMBoe), of which approximately 75.9 MMboe (64%) were in the Gulf of Mexico and 42.9 MMBoe (36%) were in the North Sea. The reserves consisted of 78.6 Million barrels (MMBbls) of oil (66%) and 241.5 billion cubic feet (Bcf) of natural gas (34%). Its proved reserves in the deepwater area of the Gulf of Mexico account for 62% of the Company’s total proved reserves and its proved reserves on the Gulf of Mexico Outer Continental Shelf account for 2% of its total proved reserves. During the year ended December 31, 2011, the Company acquired three licenses in the Mediterranean Sea covering potential natural gas resources in the deepwater off the coast of Israel (East Mediterranean). On August 17, 2012, ATP Oil And Gas C orp filed for Chapter 11 bankruptcy protection.

The Company’s natural gas reserves are split between the Gulf of Mexico (57%) and the North Sea (43%). Of its total proved reserves, 8.3 MMBoe (7%) were producing, 19.0 MMBoe (16%) were developed and not producing and 91.6 MMBoe (77%) were undeveloped. The Company’s average working interest in its properties at December 31, 2011, was approximately 81%. The Company operates 92% of its platforms. At December 31, 2011, in the Gulf of Mexico, it owned leasehold and other interests in 38 offshore blocks and 49 wells, including 23 subsea wells. The Company operates 43 (88%) of these wells, including 100% of the subsea wells. In the North Sea, it also had interests in 13 blocks and two Company-operated subsea wells. As of March 15, 2011, the Company owned an interest in 13 platforms, including two floating production facilities in the Gulf of Mexico, the ATP Titan at its Telemark Hub and the ATP Innovator at its Gome z Hub. It operates the ATP Innovator and the ATP Titan.

Advisors’ Opinion:

  • [By John Emerson]

    Most of the Chinese companies that I purchased now reside on the Pink Sheets or have disappeared altogether, but at one time they all traded on major US exchanges. One of them (AOB), even received the honor of ringing the opening bell at the New York Stock Exchange in 2007, and people say that crime does not pay.

Top Cheapest Companies To Watch For 2014: CNinsure Inc.(CISG)

CNinsure Inc., together with its subsidiaries, provides insurance brokerage and agency services, and insurance claims adjusting services in the People?s Republic of China. The company offers property, casualty, and life insurance products underwritten by domestic and foreign insurance companies operating in China. Its property and casualty insurance products include automobile, individual accident, commercial property, homeowner, cargo, hull, liability, and construction insurance; and life insurance products comprise individual whole life insurance, term life insurance, education annuity, and health insurance, as well as universal insurance and group life insurance. The company also offers insurance claims adjusting services, which include pre-underwriting survey, claims adjusting, disposal of residual value, loading and unloading supervision, and consulting services, as well as damage assessment, survey, authentication, and loss estimation to insurance companies and the i nsured; and value-added services to its customers in conjunction with distributing automobile insurance products. As of April 15, 2010, its distribution and service network consisted of 49 insurance agencies, 3 insurance brokerages, and 4 claims adjusting firms, with 571 sales and service outlets. The company was founded in 1998 and is headquartered in Guangzhou, the People?s Republic of China.

Advisors’ Opinion:

  • [By Jake L’Ecuyer]

    Financial sector was the leading decliner in the US market today. Top losers in the sector included GSV Capital (NASDAQ: GSVC), off 9.3 percent, and Cninsure (NASDAQ: CISG), down around 6.6 percent.

  • [By Monica Gerson]

    CNinsure (NASDAQ: CISG) is projected to post its Q4 earnings at $0.10 per share.

    Ferrellgas Partners LP (NYSE: FGP) is expected to report its Q2 earnings at $0.85 per share on revenue of $722.07 million.

Top Cheapest Companies To Watch For 2014: Starbucks Corporation(SBUX)

Starbucks Corporation purchases and roasts whole bean coffees. It operates approximately 16,858 stores, including 8,833 company-operated stores and 8,025 licensed stores. The company offers approximately 30 blends and single-origin premium arabica coffees. It also provides handcrafted beverages, such as fresh-brewed coffee, hot and iced espresso beverages, coffee and non-coffee blended beverages, Vivanno smoothies, and Tazo teas; and merchandise products, including home espresso machines, coffee brewers and grinders, coffee mugs and accessories, packaged goods, music, books, and gift items. In addition, it offers fresh food items, which comprise baked pastries, sandwiches, salads, oatmeal, yogurt parfaits, and fruit cups. Further, it also provides VIA ready brew coffee, bottled frappuccino beverages, discoveries chilled cup coffee, doubleshot espresso drinks, iced coffee, whole bean coffee, and ice creams. The company?s brand portfolio includes Tazo tea, Ethos water, Seatt le?s Best Coffee, and Torrefazione Italia Coffee. Starbucks Corporation sells its products in approximately 50 countries worldwide. Starbucks Corporation was founded in 1971 and is based in Seattle, Washington.

Advisors’ Opinion:

  • [By Andrés Cardenal]

    The war for breakfast is getting hotter than ever, with big fast-food companies such as Yum! Brands (NYSE: YUM  ) , McDonald’s (NYSE: MCD  ) , and Burger King (NYSE: BKW  ) intensifying their competitive pressure in that lucrative niche. On the other hand, at the higher end of the pricing spectrum, Starbucks (NASDAQ: SBUX  ) could be a clear winner in that competition thanks to its differentiated quality and successful menu innovations.

  • [By Ravagadus]

    The breakfast wars are heating up nicely in the form of a three-way challenge between McDonald’s (MCD), Yum Brands (YUM) Taco Bell and Starbucks (SBUX). The fight is on to lure unsuspecting customers from One Breakfast table to another.

  • [By Bloomberg Businessweek]

    Alamy McDonald’s (MCD) may recently have struggled to lure customers, but it still does far more business at each location than rival burger chains. The average McDonald’s restaurant in the U.S. drew $2.6 million in revenue last year. Average sales for No. 2 chain Burger King (BKW): $1.2 million, according to data from its largest franchisee, Carrols Restaurant Group (TAST). What accounts for this more-than-a-million gap? “Everything from marketing and site selection to product initiatives and franchisee selection have been historical factors,” said Nick Setyan, vice president in charge of equity research at Wedbush Securities, in an email. Here are four factors that drive higher sales volumes at McDonald’s: 1. McDonald’s gets more customers during off-peak hours. Look no further than the strength of its breakfast business relative that of Burger King, says Darren Tristano, executive vice president at restaurant consultancy Technomic. Egg McMuffin is part of the fast-food vocabulary in a way Burger King can’t match. And beverage and snack offerings such as McCafe and wraps have helped increase McDonald’s sales between meals. The dramatic impact from off-peak business explains why chains such as Taco Bell (YUM) are entering the battle for morning customers, while others such as Starbucks (SBUX) are seeking more afternoon and evening business. 2. The power of the Happy Meal. McDonald’s has the largest share of kids meal sales in the fast-food industry and gets about 10 percent of total sales from Happy Meals, the most commonly advertised child-oriented fast-food item on television. Burger King, meanwhile, is still trying to win back “parties with kids and seniors and women,” said Josh Kobza, Burger King’s chief financial officer, at a conference last year. One way to do that: “We got rid of the creepy king character that tended to scare away women and children.” 3. McDonald’s has an edge on efficiency. Despite recent operational challenges at McDonald’s,

  • [By Rick Aristotle Munarriz]

    Taco Bell/AP There will be a new player in the escalating battle for breakfast on Thursday when Yum Brands’ (YUM) Taco Bell rolls out its new morning menu, and the stakes are huge. McDonald’s (MCD) is the name that most people associate with breakfast fast food. Ever since it introduced the Egg McMuffin in 1972, the world’s largest burger flipper has set the bar for convenient morning meals for people on the go. The Waffle Taco will likely be Taco Bell’s signature breakfast item. The taco-shaped waffle wrapped around a sausage patty, scrambled eggs and cheese turned heads when it was tested in select locations late last year. However, it’s just one of the many items wooing commuters. Naturally there will be eggy breakfast burritos and grilled tacos with either bacon or sausage. The A.M. Crunchwrap gives a morning spin to the Crunchwrap Supreme by blanketing hash browns, scrambled eggs and either bacon or sausage in a pressed and folded flour tortilla. Tough Competition McDonald’s is struggling these days, but it’s still a fierce competitor when it comes to the first meal of the day. Just ask Burger King (BKW), which finds itself copying McDonald’s more often than not, including hotcakes served with sausage and the Egg McMuffin. Just ask Wendy’s (WEN), which retreated from its nationwide breakfast menu a couple of years ago. It’s starting to work its way back in by introducing breakfast in some markets. Even Starbucks (SBUX) has been feeling the threat of McDonald’s as the burger giant beefs up its McCafe line, offering guests drive-thru convenience that many Starbucks locations cannot. Earlier this month Starbucks ran a three-day promotion where it offered free coffee to anyone ordering a breakfast sandwich. It was meant to remind customers that it offers more than just java. Breakfast seems like an easy decision for a fast food leader. Who wouldn’t want to milk more revenue out of a location by extending its operating hours? However, with Wendy’s coming

Top Cheapest Companies To Watch For 2014: OGE Energy Corporation(OGE)

OGE Energy Corp., together with its subsidiaries, operates as an energy and energy services provider that offers physical delivery and related services for electricity and natural gas primarily in the south central United States. The company is involved in the generation, transmission, distribution, and sale of electric energy in Oklahoma and western Arkansas; and gathering, processing, transporting, storing, and marketing of natural gas. It furnishes retail electric service in 268 communities and their contiguous rural and suburban areas. OGE Energy Corp. operates coal-fired and natural gas-fired units, as well as wind-powered units. As of December 31, 2011, the company owned and operated 12 generating stations with an aggregate capability of 6,790 megawatts; and a transmission system comprising 51 substations and 4,258 structure miles of lines in Oklahoma, and 7 substations and 279 structure miles of lines in Arkansas. Its distribution system consisted of 353 substations , 27,854 structure miles of overhead lines, 1,895 miles of underground conduit, and 10,120 miles of underground conductors in Oklahoma, as well as 37 substations, 2,250 structure miles of overhead lines, 212 miles of underground conduit, and 572 miles of underground conductors in Arkansas. The company also owned approximately 6,019 miles of intrastate natural gas gathering pipelines in Oklahoma and Texas; approximately 2,250 miles of intrastate natural gas transportation pipelines in Oklahoma; and 2 underground natural gas storage facilities and 8 operating natural gas processing plants in Oklahoma. It serves residential, commercial, industrial, oilfield, public authorities, and street light operators. OGE Energy Corp. was founded in 1995 and is based in Oklahoma City, Oklahoma.

Advisors’ Opinion:

  • [By GURUFOCUS]

    OGE Energy Corp. (OGE) operates as an energy and energy services provider that offers physical delivery and related services for electricity and natural gas primarily in the south central U.S. Dec. 4, the company increased its quarterly dividend 7.8% to $0.225 per share. The dividend is payable Jan. 30, 2014, to shareowners of record Jan. 10, 2014. The yield based on the new payout is 2.7%.

  • [By Marc Bastow]

    Energy services provider OGE Energy (OGE) raised its annual dividend 7.8% to 90 cents per share, payable on Jan. 30 to shareholders of record as of January 10.
    OGE Dividend Yield: 2.6%

  • [By Chuck Carnevale]

    OGE Energy Corp. (OGE): Another Utility with Slightly Higher Growth

    Our second example, OGE Energy Corp., differs from our first only by virtue of the fact that its earnings growth rate since 1998 has averaged over 5% per annum. Nevertheless, we once again discover that the PE ratio of 15 represents a strong proxy for this company’s valuation. During the short time intervals when price deviates from fair value PE of 15, it doesn’t take long for price to move back into alignment with earnings.